Literature DB >> 18159094

Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease.

Noriyuki Komura1, Shinji Kihara, Mina Sonoda, Masahiro Kumada, Koichi Fujita, Aki Hiuge, Takuya Okada, Yasuhiko Nakagawa, Sachiko Tamba, Yohei Kuroda, Noriyuki Hayashi, Satoru Sumitsuji, Toshiharu Kawamoto, Satoru Matsumoto, Noriyuki Ouchi, Yukio Arita, Yoshihisa Okamoto, Iichiro Shimomura, Tohru Funahashi, Yuji Matsuzawa.   

Abstract

BACKGROUND: It has been reported previously that the measurement of plasma total adiponectin level is clinically useful to estimate the risk of coronary artery disease (CAD). Here, the relevance of high molecular weight (HMW) adiponectin with risk factors for atherosclerosis is investigated METHODS AND
RESULTS: A total of 186 consecutive male CAD patients participated in the study and were categorized into quartiles based on their total adiponectin level. The interquartile cut-off points were 4.0, 5.5 and 7.0 microg/ml. The HMW adiponectin levels were significantly lower in the quartile of lower total adiponectin levels both in non-diabetic and diabetic patients. In contrast, low molecular weight adiponectin levels (which were calculated as the Total - HMW) were constant. In univariate analysis, total adiponectin correlated negatively with body mass index and hemoglobin (Hb) A1c, and HMW adiponectin correlated negatively with HbA1c in non-diabetic patients. On the other hand, total and HMW adiponectin correlated positively with high-density lipoprotein-cholesterol (HDL-C) in diabetic patients. Multiple regression analysis revealed that HMW adiponectin correlated negatively with HbA1c in non-diabetic patients, and total and HMW adiponectin correlated positively with HDL-C in diabetic patients.
CONCLUSIONS: Change in the HMW isoform reflects a change in total adiponectin level. Measurement of total and HMW adiponectin were equally useful in assessing metabolic risk in CAD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18159094     DOI: 10.1253/circj.72.23

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  21 in total

Review 1.  Assembly of adiponectin oligomers.

Authors:  Tsu-Shuen Tsao
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

2.  Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants.

Authors:  Linda Broer; Julia Raschenberger; Joris Deelen; Massimo Mangino; Veryan Codd; Kirsi H Pietiläinen; Eva Albrecht; Najaf Amin; Marian Beekman; Anton J M de Craen; Christian Gieger; Margot Haun; Peter Henneman; Christian Herder; Iiris Hovatta; Annika Laser; Lyudmyla Kedenko; Wolfgang Koenig; Barbara Kollerits; Eeva Moilanen; Ben A Oostra; Bernhard Paulweber; Lydia Quaye; Aila Rissanen; Michael Roden; Ida Surakka; Ana M Valdes; Katriina Vuolteenaho; Barbara Thorand; Ko Willems van Dijk; Jaakko Kaprio; Tim D Spector; P Eline Slagboom; Nilesh J Samani; Florian Kronenberg; Cornelia M van Duijn; Karl-Heinz Ladwig
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

3.  Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques.

Authors:  Yoshihisa Okamoto; So Ishii; Kevin Croce; Harumi Katsumata; Makoto Fukushima; Shinji Kihara; Peter Libby; Shiro Minami
Journal:  Atherosclerosis       Date:  2012-12-25       Impact factor: 5.162

4.  Adiponectin and carotid intima-media thickness in the northern Manhattan study.

Authors:  Hannah Gardener; Charlotte Sjoberg; Milita Crisby; Ronald Goldberg; Armando Mendez; Clinton B Wright; Mitchell S V Elkind; Ralph L Sacco; Tatjana Rundek
Journal:  Stroke       Date:  2011-12-22       Impact factor: 7.914

5.  Isolation and quantitation of adiponectin higher order complexes.

Authors:  Joseph M Rutkowski; Philipp E Scherer
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

6.  Adiponectin and risk of vascular events in the Northern Manhattan study.

Authors:  Hannah Gardener; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Atherosclerosis       Date:  2012-11-28       Impact factor: 5.162

7.  Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study.

Authors:  Elaine Hui; Aimin Xu; Wing-Sun Chow; Paul C H Lee; Carol H Y Fong; Stephen C W Cheung; Hung Fat Tse; Ming-Tak Chau; Bernard M Y Cheung; Karen S L Lam
Journal:  Metab Syndr Relat Disord       Date:  2014-09-11       Impact factor: 1.894

8.  Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study.

Authors:  Hannah Gardener; Milita Crisby; Charlotte Sjoberg; Barry Hudson; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Metab Syndr Relat Disord       Date:  2012-11-05       Impact factor: 1.894

9.  Clinical and biochemical effects of a 3-week program of diet combined with spa therapy in obese and diabetic patients: a pilot open study.

Authors:  Antonella Fioravanti; Przemysław Adamczyk; Nicola Antonio Pascarelli; Chiara Giannitti; Renato Urso; Michał Tołodziecki; Irena Ponikowska
Journal:  Int J Biometeorol       Date:  2014-09-07       Impact factor: 3.787

10.  Sex differences in the associations between adiposity distribution and cardiometabolic risk factors in overweight or obese individuals: a cross-sectional study.

Authors:  Yide Yang; Ming Xie; Shuqian Yuan; Yuan Zeng; Yanhui Dong; Zhenghe Wang; Qiu Xiao; Bin Dong; Jun Ma; Jie Hu
Journal:  BMC Public Health       Date:  2021-06-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.